We're excited to share an insightful deep dive by Suki Kandola, Global Head of Value & Access, on the latest updates in the AMCP Format for Formulary Submissions Version 5.0., covering value-based care, early engagement strategies, and the importance of real-world evidence and health disparities. This piece highlights practical strategies for navigating these changes, ensuring successful product launches and better patient access. Advancing with these new insights is crucial for staying ahead in the healthcare landscape, accelerating formulary submissions, and improving patient outcomes. https://lnkd.in/gRgn_35a #Healthcare #Pharma #ValueBasedCare #PatientAccess #RealWorldEvidence #EnvisionPharma
Navigating the AMCP Format for Formulary Submissions has evolved with Version 5.0, transforming our approach to value and access strategies. No longer just a standardised process, these updates promote a more strategic and collaborative approach, focusing on early engagement, real-world evidence, and addressing health disparities. In this article, I explore: - The healthcare landscape's shift towards value-based care - Key updates in AMCP Format 5.0, including smarter early engagement, the power of real-world evidence (RWE), and the importance of addressing health disparities - Practical strategies for navigating these changes to ensure your product's successful launch and improved patient access Read my analysis of these transformative changes in my latest article with Envision Pharma Group: https://lnkd.in/didyz4-A